Your videos are an eye opener. Teaches us to update. On Tuesday, in dermpedia session, you showed ALK rearranged granular cell tumour. This was awesome.
Thank you for yet another remarkable and extremely useful lesson. I would like to make a question. Is diffuse positivity for p53 diagnostically helpful for the fibrosarcomatous transformation of a DFSP ? Thank you in advance.
I do not usually use it. I believe the interpretation of fibrosarcomatous transformation is a morphological one. Colleagues have described p53 diffuse positivity in FS-DFSP. Everytime I used it was not helpful. I suspect if there is a diffuse positivity you should scrutinize the tumor but I would not rely on this one way or the other. I don't think you need any IHC for the interpretation of FS-DFSP and if you rely on IHC it is almost certain that eventually a mistake will happen.
Your videos are an eye opener. Teaches us to update. On Tuesday, in dermpedia session, you showed ALK rearranged granular cell tumour. This was awesome.
You are a good soul.
Too good, thanks
DF with monster cells. Is it same as Atypical dermatofibroma. Bernie called them as DF with monster cells.
Thank you for yet another remarkable and extremely useful lesson. I would like to make a question. Is diffuse positivity for p53 diagnostically helpful for the fibrosarcomatous transformation of a DFSP ? Thank you in advance.
I do not usually use it. I believe the interpretation of fibrosarcomatous transformation is a morphological one. Colleagues have described p53 diffuse positivity in FS-DFSP. Everytime I used it was not helpful. I suspect if there is a diffuse positivity you should scrutinize the tumor but I would not rely on this one way or the other. I don't think you need any IHC for the interpretation of FS-DFSP and if you rely on IHC it is almost certain that eventually a mistake will happen.
@@klinos thank you for the advice.
Bernie always considered DFSP as benign not sarcoma
With molecular classification, morphological interpretation is getting ambiguous / not apt.